期刊文献+

药物化学和生物利用度控制 被引量:2

MEDICINAL CHEMISTRY AND BIOAVAILABILITY MANIPULATIONS
下载PDF
导出
摘要 目的 :就 2 1世纪药物化学所关注的 4个问题 ,着重综述药物化学对生物利用度控制的意义。方法 :以实例说明。结果 :药物化学方法有助于防止药物的首过代谢 ,提高其生物利用度 ;获得部位专一传输药物 ;获得部位专一生物活化药物 ;肽类的前药衍生物 ,以克服肽类的传输障碍 ;用大分子载体作为药物寻靶的工具。结论 :是推出新药的简易途径。 OBJECTIVE:The 4 aspects of medicinal chemistry for 21st century was followed with great interest.One of them was bioavailability manipulations, and its significance was reviewed mainly.METHODS: It was discribed with theory and examples.RESULTS: these methods were helpful for (1) preventing first pass metabolism,and raising drug bioavailability;(2) gaining the site-specific delivery drugs;(3) gaining the site specific bioactivation drugs;(4)prodrug derivatives of peptides,overcoming their poor delivery characteristics;(5) macromolecular carriers for drug targeting.CONCLUSION: It is a easier way to present the new drugs.
机构地区 北京大学药学院
出处 《华西药学杂志》 CAS CSCD 北大核心 2000年第5期364-366,共3页 West China Journal of Pharmaceutical Sciences
关键词 药物化学 生物利用度控制 部位专一传输 Bioavailability Prodrugs Site specific delivery site Specific bioactivation marcromolecular carriers
  • 相关文献

参考文献10

  • 1王红武,陈凯先,嵇汝运.三维定量构效关系的研究与应用[J].国外医学(药学分册),1993,20(6):325-332. 被引量:4
  • 2Tayler JB,Kennewell PD.Introductory medicinal chemistry[]..1981
  • 3Lindberg P,Nordberg P,Alminger T,et al.The mechanism of action of the gastric acid secretion inhibitor omeprazole[].Journal of Medicinal Chemistry.1986
  • 4Humblet C,Marshall GR.Pharmacophore idetification and receptor mapping[].Annual Reports in Medicinal Chemistry.1980
  • 5Aungst BJ,Myers MJ,Shefter E,et al.Prodrug for improved oral nalbuphine bioavailability[].International Journal of Pharmaceutics.1987
  • 6Brueggemeier RW,Miller DD,Witiak DT,et al.Principles of medicinal chemistry , 4th ed[]..1995
  • 7Wermuth CG,Koga N,Konig H,et al.Medicinal Chemistry for 21st century[]..1994
  • 8Albert A.Chemical aspects of selective toxocity[].Nature.1958
  • 9Wermuth CG.The practice of medicinal chemistry[]..1996
  • 10Schacht EH,Vansteenkiste S,Seymour L.The practice of medicinal chemistry[]..1996

共引文献3

同被引文献23

  • 1颜铮,黄文龙,彭司勋,华维一,吉念宁.3,4─二酰氧基苯骈吡喃类化合物的生物活性及定量构效关系研究[J].中国药物化学杂志,1996,6(4):235-242. 被引量:2
  • 2孙科,王继良,邹澄,赵庆,余琴,张荣平.岩白菜素含氮衍生物的仿生合成[J].中国民族民间医药,2007,16(5):256-258. 被引量:6
  • 3Gan B. Bajracharya. Diversity,pharmacology and synthesis of bergenin and its derivatives:Potential materials for thera- peutic usages[J]. Fitoterapia,2015,101 : 133-152.
  • 4Nighat Nazir, Surrinder Koul, Mushtaq Ahmad Qurishi, et al. Evaluation of antioxidant and antimicrobial activities of Bergenin and its derivatives obtained by chemoenzymatic synthesis [J]. European Journal of Medicinal Chemistry, 2011,46(6) :2415-2420.
  • 5Rajesh Kumar, Dinesh K. Patel,Satyendra K. Prasad,et al. Type 2 antidiabetic activity of bergenin from the roots of Cae- salpinia digyna Rottler[J]. Fitoterapia,2012,83(2).395--401.
  • 6Sonia Piacente, Cosimo Pizza, Nunziatina De Tommasi, et al. Constituents of Ardisia japonica and Their in Vitro Anti- HIV Activity[J]. J Nat Prod, 1996,59(6) : 565-569.
  • 7T. Vijaya Kumar,Ashok K. Tiwari. Synthesis and antigly- cation potentials of bergenin derivatives [J]. Bioorg Med Chem Lett, 2011,21 (16) : 4928-4931.
  • 8Shreyans K. Jain,Surjeet Singh,Anamika Khajuria,et al. Pyrano -isochromanones as IL -6 Inhibitors : Synthesis, in Vitro and inVivo Antiarthritic Activity [J]. J Med Chem, 2014,57(16) :7085-7097.
  • 9Yusei Kashima, Hidehiko Yamaki,Takuya Suzuki, et al. Structure-activity relationships of bergenin derivatives ef- fect on c-glucosidase inhibition[J]. Journal of Enzyme In- hibition and Medicinal Chemistry,2013,28 (6):1162- 1170.
  • 10孙科,王继良,邹澄,赵庆,余琴,邵曰凤,张荣平.岩白菜素的Mannich反应[J].云南中医学院学报,2008,31(2):25-27. 被引量:6

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部